Kowalski Christopher, Ridenour Ryan, McNutt Sarah, Ba Djibril, Liu Guodong, Bible Jesse, Aynardi Michael, Garner Matthew, Leslie Douglas, Dhawan Aman
Department of Orthopaedics & Rehabilitation, 12311Penn State Milton S. Hershey Medical Center, Hope Drive, Hershey, PA, USA.
Global Spine J. 2023 Apr;13(3):683-688. doi: 10.1177/21925682211003854. Epub 2021 Apr 15.
Retrospective review.
Our purpose was to evaluate factors associated with increased risk of prolonged post-operative opioid pain medication usage following spine surgery, as well as identify the risk of various post-operative complications that may be associated with pre-operative opioid usage.
The MarketScan commercial claims and encounters database includes approximately 39 million patients per year. Patients undergoing cervical and lumbar spine surgery between the years 2005-2014 were identified using CPT codes. Pre-operative comorbidities including DSM-V mental health disorders, chronic pain, chronic regional pain syndrome (CRPS), obesity, tobacco use, medications, and diabetes were queried and documented. Patients who utilized opioids from 1-3 months prior to surgery were identified. This timeframe was chosen to exclude patients who had been prescribed pre- and post-operative narcotic medications up to 1 month prior to surgery. We utilized odds ratios (OR), 95% Confidence Intervals (CI), and regression analysis to determine factors that are associated with prolonged post-operative opioid use at 3 time intervals.
553,509 patients who underwent spine surgery during the 10-year period were identified. 34.9% of patients utilized opioids 1-3 months pre-operatively. 25% patients were still utilizing opioids at 6 weeks, 17.3% at 3 months, 12.7% at 6 months, and 9.0% at 1 year after surgery. Pre-operative opioid exposure was associated with increased likelihood of post-operative use at 6-12 weeks (OR 5.45, 95% CI 5.37-5.53), 3-6 months (OR 6.48, 95% CI 6.37-6.59), 6-12 months (OR 6.97, 95% CI 6.84-7.11), and >12 months (OR 7.12, 95% CI 6.96-7.29). Mental health diagnosis, tobacco usage, diagnosis of chronic pain or CRPS, and non-narcotic neuromodulatory medications yielded increased likelihood of prolonged post-op opioid usage.
Pre-operative narcotic use and several patient comorbidities diagnoses are associated with prolonged post-operative opioid usage following spine surgery. Chronic opioid use, diagnosis of chronic pain, or use of non-narcotic neuromodulatory medications have the highest risk of prolonged post-operative opioid consumption. Patients using opiates pre-operatively did have an increased 30 and 90-day readmission risk, in addition to a number of serious post-operative complications. This data provides spine surgeons a number of variables to consider when determining post-operative analgesia strategies, and provides health systems, providers, and payers with information on complications associated with pre-operative opioid utilization.
回顾性研究。
我们的目的是评估脊柱手术后阿片类药物术后使用时间延长风险增加的相关因素,并确定可能与术前使用阿片类药物相关的各种术后并发症风险。
MarketScan商业索赔和就诊数据库每年约有3900万患者。使用CPT编码识别2005年至2014年间接受颈椎和腰椎手术的患者。查询并记录术前合并症,包括DSM-Ⅴ心理健康障碍、慢性疼痛、慢性区域疼痛综合征(CRPS)、肥胖、吸烟、药物使用和糖尿病。识别术前1至3个月使用阿片类药物的患者。选择该时间段以排除术前1个月内已开具术前和术后麻醉药物的患者。我们使用比值比(OR)、95%置信区间(CI)和回归分析来确定在3个时间间隔与术后阿片类药物使用时间延长相关的因素。
确定了10年间接受脊柱手术的553509例患者。34.9%的患者术前1至3个月使用阿片类药物。术后6周仍有阿片类药物使用的患者占25%;术后3个月为17.3%;术后6个月为12.7%;术后1年为9.0%。术前阿片类药物暴露与术后6至12周(OR 5.4